Eton Pharmaceuticals (ETON) Return on Invested Capital (2023 - 2025)

Eton Pharmaceuticals has disclosed Return on Invested Capital across 3 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q4 2025 at Eton Pharmaceuticals, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2025 to a low of 0.0% in Q2 2024.
• The 3-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.0%.
• Peak annual rise in Return on Invested Capital reached 0 bps in 2024, while the deepest fall reached 0 bps in 2024.
• Eton Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2023, then surged by 76 bps to 0.0% in 2024, then slumped by 47 bps to 0.0% in 2025.
• The last three Return on Invested Capital figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.